A phase II clinical trial of leuprolide for enhancement of immune reconstitution after ex vivo CD34+ cell-selected allogeneic HCT with TBI-based conditioning Meeting Abstract

  

Authors:	Cho, C.; Devlin, S. M.; Avecilla, S. T.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Maloy, M.; Maslak, P.; O'Reilly, R. J.; Papadopoulos, E. B.; Smith, K.; Tamari, R.; van den Brink, M. R. M.; Perales, M. A.
Abstract Title:	A phase II clinical trial of leuprolide for enhancement of immune reconstitution after ex vivo CD34+ cell-selected allogeneic HCT with TBI-based conditioning
Meeting Title:	45th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Journal Title:	Bone Marrow Transplantation
Volume:	54
Issue:	Suppl. 1
Meeting Dates:	2019 Mar 24-27
Meeting Location:	Frankfurt, Germany
ISSN:	0268-3369
Publisher:	Nature Publishing Group
Date Published:	2019-07-03
Start Page:	114
End Page:	115
Language:	English
ACCESSION:	WOS:000487707800115
PROVIDER:	wos
PUBMED:	31270397
DOI:	10.1038/s41409-019-0562-9
Notes:	Meeting Abstract: O145 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/155975